Monograph
V08AB09 - Iodixanol |
Not porphyrinogenic |
NP |
Rationale
No significant biotransformation.
Chemical description
Watersoluble iodated X-ray contrast medium. Excreted in unchanged form.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Visipaque · Visipaque 270 mg I/ml, oplossing voor injectie · Visipaque 320 mg I/ml, oplossing voor injectieBelgium
Visipaque · Visipaque 270 mg I/ml sol. inj. i.théc./i.artér./i.v./i.cavern. flac. · Visipaque 320 mg I/ml sol. inj. i.théc./i.artér./i.v./i.cavern. flac.United Kingdom
Visipaque · Visipaque 270 solution for injection 500ml bottles · Visipaque 320 solution for injection 500ml bottles · Visipaque 270 · Visipaque 270 solution for injection 100ml bottles · Visipaque 270 solution for injection 200ml bottles · Visipaque 270 solution for injection 20ml bottles · Visipaque 270 solution for injection 40ml bottles · Visipaque 270 solution for injection 50ml bottles · Visipaque 320 · Visipaque 320 solution for injection 100ml bottles · Visipaque 320 solution for injection 200ml bottles · Visipaque 320 solution for injection 20ml bottles · Visipaque 320 solution for injection 40ml bottles · Visipaque 320 solution for injection 50ml bottlesDenmark
VisipaqueNorway
VisipaquePoland
VisipaqueLuxembourg
VISIPAQUE · VISIPAQUE-270 · VISIPAQUE-320Iceland
VisipaqueFinland
VisipaqueLatvia
VisipaqueSerbia
Visipaque · Visipaque™
© NAPOS 2024